Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer's disease. Επικοινωνία Submitted by Δημήτρης Σπάχος on Πέμ, 12/03/2020 - 20:36
